glp 1 meds and pregnancy Study links GLP-1 use to some risks — but the research has key caveats How GLP-1 medications are transforming

(N=13) found that isotretinoin reduced brain metabolic activity in the orbitofrontal cortex, a region involved in mood regulation, whereas the antibiotic control group showed no such change

The risks and side effects are different and the injection sites need to be considered seriously

Increased release of glutamate from presynaptic terminals activates N -methyl-D-aspartate (NMDA) receptors on postsynaptic terminals to lead to a widespread neuronal depolarization or spreading depression, further disrupting the sodium ion, potassium ion, and calcium ion equilibria (Langlois et al., 2006)

"Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response." Gut , 2019